explore -WSS

explore

author：fashion 2025-09-28 06:09:07 - browse：96237

Illustration of a person holding a phone with apps and small people (patients and doctors) on the screen. -- chronic disease coverage from STAT — Molly Ferguson for STAT

If her neurologist moved to China, Lauren Stiles says she’d follow him there. “There’s so few doctors who do this,” said the New York-based president of patient advocacy group Dysautonomia International.

In her world, informed, experienced specialists — particularly in the autonomic nervous system — are extremely rare. Telehealth can open doors for patients who have been searching for a doctor who understands them. Stiles had to travel hundreds of miles to find an expert at the Cleveland Clinic who could diagnose her (it took two years to figure out she has postural orthostatic tachycardia syndrome, or POTS, and Sjögren’s syndrome). When that last-ditch doctor moved to Virginia, she followed him.

But many times, Stiles has questions that shouldn’t take a dozen-hour road trip to answer. She’d love to call him up and have an appointment over the phone.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Redefining sustainability for the pharmaceutical industry

leisure time

focus

WSS

Roivant's CEO is a star, but biotech's black hole persists

STAT Readout Newsletter: Biotech news today

NEJM study measures Covid brain fog, impact on IQ

Readout Newsletter: Beam, Prozac, "TechBio" and more

Change Healthcare cyberattack shows risk of industry consolidation

Pfizer is about to make a big push in cancer. Will investors listen?

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Medical records are filled with copy

Questions loom on AstraZeneca cancer drug as safety concerns ebb

At least 13 dead in Texas as scorching temps continue

Why a market frenzy over new weight loss drugs defies logic

Walensky prepares to leave CDC — and Congress — behind

Why a market frenzy over new weight loss drugs defies logic

State Dept. review finds Biden bears some blame for Afghanistan failures

Are embryos people? Reproductive medicine's future depends on the answer

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Madness 2024: Meet the contenders

entertainment

Results on Novartis prostate cancer therapy could expand its use

STAT Readout: Friday, Oct. 20 biotech updates

Roche drug slashes death risk in early

Children’s Hospital revives plan for pedestrian bridge

UnitedHealth, Optum discontinue NaviHealth name

Is there really a nursing shortage in the U.S.?

leisure time

knowledge

focus

hotspot